Optimal usage of radium-223 in metastatic castration-resistant prostate cancer

被引：14
|
作者：
Cha, Tai-Lung [1 ]
Wu, Tony Tong-Lin [2 ]
Vogelzang, Nicholas John [3 ,13 ]
Huang, Chao-Yuan [4 ]
Huang, Shu-Pin [5 ]
Lin, Chia-Chi [6 ]
Ou, Yen-Chuan [7 ]
Pang, See-Tong [8 ]
Shen, Daniel Heung-Yuan [9 ]
Wu, Wen-Jeng [10 ]
Chang, Wayne Yen-Hwa [11 ,12 ]
机构：
[1] Natl Def Med Ctr, Div Urol, Dept Surg, Triserv Gen Hosp, Taipei, Taiwan
[2] Kaohsiung Vet Gen Hosp, Div Urol, Dept Surg, Kaohsiung, Taiwan
[3] Univ Nevada, Sch Med, Med Oncol Comprehens Canc Ctr Nevada, Las Vegas, NV 89154 USA
[4] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan
[5] Kaohsiung Med Univ, Dept Urol, Chung Ho Mem Hosp, Kaohsiung, Taiwan
[6] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[7] Taichung Vet Gen Hosp, Div Urol, Dept Surg, Taichung, Taiwan
[8] Chang Gung Mem Hosp, Div Urol, Dept Surg, Linkou, Taiwan
[9] Natl Def Med Ctr, Dept Nucl Med, Triserv Gen Hosp, Taipei, Taiwan
[10] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Urol, Chung Ho Mem Hosp, Kaohsiung, Taiwan
[11] Taipei Vet Gen Hosp, Div Gen Urol, Dept Urol, Taipei, Taiwan
[12] Natl Yang Ming Univ, Dept Urol, Sch Med, Taipei, Taiwan
[13] Comprehens Canc Ctr Nevada, 3730 S Eastern Ave, Las Vegas, NV 89169 USA
来源：
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2017年 / 116卷 / 11期
关键词：
Radium chloride Ra 223; Radiopharmaceuti-cals; PAINFUL BONE METASTASES; DOUBLE-BLIND; CLINICAL-EXPERIENCE; PHASE-III; CHLORIDE; SURVIVAL; THERAPY; MULTICENTER; PALLIATION; DICHLORIDE;
D O I：
10.1016/j.jfma.2017.04.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Radium-223 is a first-in-class alpha-emitting radiopharmaceutical that targets bone metastases associated with metastatic castration-resistant prostate cancer (mCRPC). In the pivotal phase III trial ALSYMPCA, radium-223 significantly increased overall survival (OS), compared with placebo (median 14.9 vs 11.3 months; hazard ratio 0.70; 95% CI 0.58-0.83; p < 0.001), in patients with mCRPC and symptomatic bone metastasese-with a comparable safety profile.
引用
下载
收藏
页码：825 / 836
页数：12
相关论文
共 50 条
  • [1] RADIUM-223: TREATING METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    James, D.
    Hillery, R.
    Freeman, L.
    Kumari, A.
    Kearney, N.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 30 - 31
  • [2] Radium-223 In The Treatment Of Metastatic Castration-Resistant Prostate Cancer
    Vazzana, C.
    Morano, S.
    Di Lascio, A.
    Grana, C.
    Chinol, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S880 - S880
  • [3] Use of Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer
    Parker, Chris
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (11) : 723 - 725
  • [4] Radium-223 in the therapeutic sequence of metastatic castration-resistant prostate cancer
    Unda-Urzaiz, M.
    Sousa-Campo, R.
    Rodriguez-Antolin, A.
    Silva-Marins, C.
    Juarez-Soto, A.
    Minana-Lopez, B.
    Figueiredo-de Castro, A.
    Cozar-Olmos, J. M.
    ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (04): : 227 - 237
  • [5] Efficacy of radium-223 dichloride in castration-resistant metastatic prostate cancer
    Sobrevilla Calvo, Pedro de Jesus
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 : 26 - 27
  • [6] The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer
    Heinrich, Daniel
    Bektic, Jasmin
    Bergman, Andries M.
    Caffo, Orazio
    Cathomas, Richard
    Chi, Kim N.
    Daugaard, Gedske
    Keizman, Daniel
    Kindblom, Jon
    Kramer, Gero
    Olmos, David
    Omlin, Aurelius
    Sridhar, Srikala S.
    Tucci, Marcello
    van Oort, Inge
    Nilsson, Sten
    CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : E223 - E231
  • [7] Radium-223 for the treatment of castration-resistant prostate cancer
    El-Amm, Joelle
    Aragon-Ching, Jeanny B.
    ONCOTARGETS AND THERAPY, 2015, 8 : 1103 - 1109
  • [8] Radium-223 in metastatic castration resistant prostate cancer
    Vuong, Winston
    Sartor, Oliver
    Pal, Sumanta K.
    ASIAN JOURNAL OF ANDROLOGY, 2014, 16 (03) : 348 - 353
  • [9] Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
    Yong Du
    Ignasi Carrio
    Giuseppe De Vincentis
    Stefano Fanti
    Harun Ilhan
    Caroline Mommsen
    Egbert Nitzsche
    Francis Sundram
    Wouter Vogel
    Wim Oyen
    Val Lewington
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1671 - 1678
  • [10] Radium-223 and metastatic castration-resistant prostate cancer: All that glitters is not gold
    Aprile, Carlo
    Persico, Marco G.
    Lodola, Lorenzo
    Buroni, Federica E.
    WORLD JOURNAL OF RADIOLOGY, 2016, 8 (10): : 816 - 818
12345